{Reference Type}: Journal Article
{Title}: NCAPG2 contributes to the progression of malignant melanoma through regulating proliferation and metastasis.
{Author}: Feng Z;Zhang L;Liu Y;Zhang W;
{Journal}: Biochem Cell Biol
{Volume}: 100
{Issue}: 6
{Year}: 12 2022 1
{Factor}: 3.73
{DOI}: 10.1139/bcb-2022-0048
{Abstract}: Malignant melanoma is a highly aggressive cutaneous neoplasm with increasing incidence worldwide. Non-SMC condensin II complex subunit G2 (NCAPG2) exerts import biological function in the pathogenesis of several tumors. In this study, the functional roles of NCAPG2 knockdown in malignant melanoma were revealed in in vitro and in vivo experiments. In vitro study demonstrated that NCAPG2 depletion could inhibit proliferation and migration and promote apoptosis of malignant melanoma cells. Our in vivo date further confirmed that NCAPG2 knockdown attenuated tumor growth of malignant melanoma. Interestingly, NCAPG2 drove tumor development of malignant melanoma through activating the signal transducer and activator of transcription 3 (STAT3). In conclusion, this study elaborated the tumor-promoting effects of NCAPG2 on malignant melanoma, and NCAPG2 may be a potential therapeutic target for malignant melanoma therapy.